• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Friday, November 20, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

Systemic Filgrastim Increases Repaired Achilles Tendon Strength in Rat Study

by
November 20, 2026
in Health
Reading Time: 3 mins read
0
Systemic Filgrastim Increases Repaired Achilles Tendon Strength in Rat Study

Systemic Filgrastim Increases Repaired Achilles Tendon Strength in Rat Study

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Short-term systemic administration of filgrastim during the early postoperative period significantly increased the maximum load to failure of surgically repaired Achilles tendons in female rats evaluated at 28 days. Achilles tendon healing typically involves prolonged extracellular matrix remodeling and an incomplete restoration of native mechanical properties. While granulocyte colony-stimulating factor has been suggested to support tissue repair, its independent effect on tendon healing remained unclear prior to this controlled experimental investigation.

To evaluate the independent biomechanical and structural effects of the agent, the researchers conducted an animal study testing two distinct dosage levels of systemic filgrastim against a control solution following primary tendon repair. The investigation examined whether granulocyte colony-stimulating factor therapy could improve structural tensile strength and promote more favorable histological characteristics during the critical four-week healing window.

The experimental protocol utilized 36 female Wistar albino rats randomly allocated into three equal groups of 12 animals each: a control group, a low-dose filgrastim group receiving 10 µg/kg/day, and a high-dose filgrastim group receiving 30 µg/kg/day. All animals underwent bilateral Achilles tenotomy followed immediately by primary surgical repair. Filgrastim or a 5% dextrose vehicle control was administered subcutaneously once daily for five consecutive days during the early postoperative period.

At postoperative day 28, tissue healing was evaluated through comprehensive biomechanical tensile testing, Updated Bonar histological scoring, and Picrosirius Red polarization birefringence analysis. The investigators also conducted immunohistochemical assessments targeting collagen type I alpha 1 chain, collagen type III alpha 1 chain, and platelet endothelial cell adhesion molecule-1, alongside exploratory serum cytokine measurements. Maximum force was designated as the primary outcome, histological and immunohistochemical parameters served as secondary outcomes, and cytokine profiles were treated as exploratory endpoints, with group comparisons analyzed via one-way ANOVA, Welch’s ANOVA, or Kruskal–Wallis tests.

Biomechanical evaluation revealed that maximum force to failure was significantly higher in both the low-dose cohort (57.49 ± 13.98 N) and the high-dose cohort (62.01 ± 14.64 N) than in the control animals (24.17 ± 11.97 N; p < 0.001 for both comparisons). Notably, there was no statistically significant difference in maximum force between the 10 µg/kg/day and 30 µg/kg/day dosage regimens, indicating that tripling the dose did not produce an additional increase in gross tensile load capacity.

Histological examinations demonstrated that total Updated Bonar scores were lower in both treated cohorts compared to controls, with the lowest scores recorded in the high-dose group, reflecting improved tissue architecture. In addition, filgrastim treatment was associated with a higher red–orange to green birefringence ratio under Picrosirius Red polarization, signaling a higher proportion of mature, organized collagen fibers within the healing repair zone.

Immunohistochemical analysis further supported a more mature remodeling profile in treated tendons. Tendons from animals receiving filgrastim exhibited higher immunoreactivity for collagen type I alpha 1 chain and lower immunoreactivity for collagen type III alpha 1 chain relative to controls, indicating an accelerated transition toward mature collagen architecture. Furthermore, the treated groups demonstrated lower microvessel density as measured by platelet endothelial cell adhesion molecule-1 immunoreactivity, consistent with advanced remodeling progression.

Exploratory serum cytokine assessments revealed nominal alterations among systemic inflammatory markers without broad multi-pathway activation. Specifically, serum interleukin-6 was nominally lower and tumor necrosis factor-α was nominally higher in the high-dose filgrastim group compared to other cohorts, whereas serum levels of interleukin-1β and transforming growth factor-β did not differ significantly across experimental groups.

In their conclusions, the authors noted that early short-term systemic filgrastim administration increased maximum tensile failure load and fostered a more mature histological and immunohistochemical remodeling profile at 28 days post-repair. However, because the higher dose improved selected histological indices without yielding any corresponding increase in mechanical load to failure, the experimental data did not establish a dose–response relationship.

Subject of Research: Biomechanical and histological effects of systemic filgrastim on rat Achilles tendon repair

Article Title: Systemic filgrastim increases maximum load to failure of repaired Achilles tendons in rats: a biomechanical, histopathological, and immunohistochemical study

Article References: Yetkin, H., Ekici, M., & DoÄŸan, M. (2026). Systemic filgrastim increases maximum load to failure of repaired Achilles tendons in rats: a biomechanical, histopathological, and immunohistochemical study. Journal of Orthopaedic Surgery and Research. https://doi.org/10.1186/s13018-026-07342-w

Image Credits: AI Generated

DOI: 10.1186/s13018-026-07342-w

Keywords: filgrastim, Achilles tendon repair, biomechanical testing, maximum load to failure, granulocyte colony-stimulating factor, Wistar albino rats, Updated Bonar score, Picrosirius Red birefringence, collagen type I alpha 1, collagen type III alpha 1, platelet endothelial cell adhesion molecule-1, tenotomy, tissue remodeling, interleukin-6, tumor necrosis factor-alpha, microvessel density

News Source: Ophelia Keating. (November 20, 2026). Systemic Filgrastim Increases Repaired Achilles Tendon Strength in Rat Study. Scienmag.

Tags: Achilles tendon repairbiomechanical testingcollagen type I alpha 1collagen type III alpha 1filgrastimGranulocyte colony-stimulating factorinterleukin-6maximum load to failuremicrovessel densityPicrosirius Red birefringenceplatelet endothelial cell adhesion molecule-1tenotomytissue remodelingtumor necrosis factor-alphaUpdated Bonar scoreWistar albino rats
Share12Tweet7Share2ShareShareShare1

Related Posts

Machine Learning Model Identifies Key Biomarkers Predicting Zoster Nerve Pain Relief

Machine Learning Model Identifies Key Biomarkers Predicting Zoster Nerve Pain Relief

November 20, 2026
German Inpatient Multiple Sclerosis Admissions Dropped 28 Percent From 2019 to 2024

German Inpatient Multiple Sclerosis Admissions Dropped 28 Percent From 2019 to 2024

November 20, 2026

Tangeretin Protects Neural Cells from Oxygen and Glucose Deprivation in Laboratory Study

November 20, 2026

Nerve Ultrasound Detects Hidden Peripheral Damage in Leprosy Patients in India

November 20, 2026

POPULAR NEWS

  • Astrocytic GFAP Upregulation Reduces Tau Pathology in Mouse Model of Tauopathy

    Astrocytic GFAP Upregulation Reduces Tau Pathology in Mouse Model of Tauopathy

    29 shares
    Share 12 Tweet 7
  • Acidic Ponds Link to Lower Pathogen Prevalence in Palmate Newts

    29 shares
    Share 12 Tweet 7
  • Early YAP and Beta-Catenin Signaling Links Stomach Infection to Liver Colonization

    29 shares
    Share 12 Tweet 7
  • Cold Storage Preserves Peach Firmness by Triggering RNA Degradation of Expansin Transcripts

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Recycled Carbon Fibers Boost Concrete Axial Compressive Strength by 18.8 Percent

Machine Learning Model Identifies Key Biomarkers Predicting Zoster Nerve Pain Relief

Stochastic Theory Translates Cartesian Ornstein-Uhlenbeck Dynamics Directly Into Organism-Centered Comoving Frames

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 89 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.